Chloroprocaine hydrochloride - Sintetica

Alternative Names: AMP-100; Ampres; chloroprocaine HCL - Sintetica; Clorotekal; IHEEZO

Latest Information Update: 19 Feb 2024

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Sintetica
Class Amines; Benzoates; Local anaesthetics; Small molecules
Mechanism of Action Sodium channel antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Anaesthesia

Most Recent Events

19 Feb 2024 Apotex in-licenses exclusive rights for manufacturing and commercialization of chloroprocaine hydrochloride from Harrow in Canada
29 Sep 2023 Harrow Health is now called Harrow
04 May 2023 Launched for Anaesthesia in USA (Ophthalmic)

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight